FEBRUARY 2021

23 February 2021 – Patrys Achieves Major Development Milestone

DECEMBER 2020

18 December 2020 – Patrys’ PAT-DX1 Hijacks a Nucleoside Transporter to Cross Cell Membranes

SEPTEMBER 2020

30 September 2020 – Major Cancer Deals in DNA Damage Repair

9 September 2020 – Understanding the Blood Brain Barrier (BBB)

8 September 2020 – Janssen Shows Interest in SLE Antibodies

JULY 2020

22 July 2020 – Patrys -Synthetic Lethality to Kill Cancer Cells

APRIL 2020

22 April 2020 – DDR Therapeutics and Synthetic Lethality a Precise Way to Kill Cancer Cells

20 April 2020 – Exploiting the DNA Damage Response Pathway to Treat Cancer

OCTOBER 2018

19 October 2018 – Patrys Selects Indications for Unique Cancer Treatment Approach

SEPTEMBER 2018

10 September 2017 – Nuclear-penetrating DNA binding antibodies as cancer therapies

SEPTEMBER 2017

14 September 2017 – Aussie cancer drug developer jumps 400pc after human tissue tests